H.C. Wainwright Downgrades Xenetic Biosciences (XBIO) to Neutral, 'Waiting For Line of Sight to Clinic'
Tweet Send to a Friend
(Updated - May 16, 2023 6:05 AM EDT)
H.C. Wainwright analyst Joseph Pantginis downgraded Xenetic Biosciences (NASDAQ: XBIO) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
H.C. Wainwright analyst Joseph Pantginis downgraded Xenetic Biosciences (NASDAQ: XBIO) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
